Royce & Associates’s Legence Corp LGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.4M Buy
368,619
+1,766
+0.5% +$144K 0.25% 108
2026
Q1
$20.7M Buy
366,853
+28,978
+9% +$1.46M 0.2% 137
2025
Q4
$14.5M Buy
337,875
+305,865
+956% +$12.1M 0.15% 209
2025
Q3
$986K Buy
+32,010
New +$1.01M 0.01% 668

Other funds holding LGN

Royce & Associates's LGN Position: Q2 2026 in Review

Royce & Associates increased its Legence Corp (LGN) stake by 0.48% in Q2 2026, buying an estimated $144K and bringing the position to 368,619 shares worth $31.4M. The position accounts for 0.25% of the portfolio, ranked #108.

Royce & Associates first reported a position in LGN in Q3 2025 and has held it in 4 quarters since. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

  • Royce & Associates held 368,619 shares of Legence Corp worth $31.4M as of Q2 2026.
  • Royce & Associates bought 1,766 Legence Corp shares in Q2 2026, an estimated $144K.
  • Legence Corp made up 0.25% of Royce & Associates's portfolio in Q2 2026, its #108 holding.
  • Royce & Associates first reported a position in Legence Corp in Q3 2025 and has held it in 4 quarters since.
  • 267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.